Dr Daniel Shao-Weng Tan is a medical oncologist. He graduated from University College London, with an Intercalated Bachelor of Science degree in Tumour Biology, 1st Class (Honours), and MBBS from St. Bartholomew’s and Royal London Hospital School of Medicine and Dentistry. He has received multiple international research awards including the ASCO Cancer Foundation Young Investigator Award and ASCO Cancer Foundation Merit Award. His research interests are in drug development and molecular biology of thoracic cancers. He is directly involved in developing protocols testing new drug targets and combinations in various cancers. His areas of specific interest are in drug resistance, with particular emphasis on lung cancer and the PI3K pathway.